相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The lingering mysteries of metastatic recurrence in breast cancer
Alessandra I. Riggio et al.
BRITISH JOURNAL OF CANCER (2021)
Dormant disseminated tumor cells and cancer stem/progenitor-like cells: Similarities and opportunities
Omri Hen et al.
SEMINARS IN CANCER BIOLOGY (2020)
A Phase I Trial Using a Multitargeted Recombinant Adenovirus 5 (CEA/MUC1/Brachyury)-Based Immunotherapy Vaccine Regimen in Patients with Advanced Cancer
Margaret E. Gatti-Mays et al.
ONCOLOGIST (2020)
GD2-targeted chimeric antigen receptor T cells prevent metastasis formation by elimination of breast cancer stem-like cells
Christian M. Seitz et al.
ONCOIMMUNOLOGY (2020)
Inhibition of MDSC Trafficking with SX-682, a CXCR1/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer Models
Sarah Greene et al.
CLINICAL CANCER RESEARCH (2020)
Circulating tumor cells in cancer patients: developments and clinical applications for immunotherapy
Xiaoming Zhong et al.
MOLECULAR CANCER (2020)
Towards personalized treatment for early stage HER2-positive breast cancer
Kristina Goutsouliak et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer
R. K. Murthy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer
Shanu Modi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Evaluating the Polarization of Tumor-Associated Macrophages Into M1 and M2 Phenotypes in Human Cancer Tissue: Technicalities and Challenges in Routine Clinical Practice
Sharmilla Devi Jayasingam et al.
FRONTIERS IN ONCOLOGY (2020)
The force awakens: metastatic dormant cancer cells
So-Yeon Park et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
Association of Th2 high tumors with aggressive features of breast cancer.
Yoshihisa Tokumaru et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
MINDACT: Long-term results of the large prospective trial testing the 70-gene signature MammaPrint as guidance for adjuvant chemotherapy in breast cancer patients.
Fatima Cardoso et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
Yuanyuan Zhang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Effect of Adjuvant Paclitaxel and Carboplatin on Survival in Women With Triple-Negative Breast Cancer A Phase 3 Randomized Clinical Trial
Ke-Da Yu et al.
JAMA ONCOLOGY (2020)
Th1 cytokines in conjunction with pharmacological Akt inhibition potentiate apoptosis of breast cancer cells in vitro and suppress tumor growth in vivo
Loral Showalter et al.
Oncotarget (2020)
Metastatic Colonization: Escaping Immune Surveillance
Julien Schaller et al.
CANCERS (2020)
Clinical development of immunotherapies for HER2+ breast cancer: a review of HER2-directed monoclonal antibodies and beyond
Ricardo L. B. Costa et al.
NPJ BREAST CANCER (2020)
CXCR4 and JUNB double-positive disseminated tumor cells are detected frequently in breast cancer patients at primary diagnosis
Galatea Kallergi et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2020)
Switchable CAR-T cells mediate remission in metastatic pancreatic ductal adenocarcinoma
Deepak Raj et al.
GUT (2019)
Progress in adjuvant systemic therapy for breast cancer
Noam F. Ponde et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
A Novel ACKR2-Dependent Role of Fibroblast-Derived CXCL14 in Epithelial-to-Mesenchymal Transition and Metastasis of Breast Cancer
Elin Sjoberg et al.
CLINICAL CANCER RESEARCH (2019)
CDK 4/6 Inhibitors in Breast Cancer: Current Controversies and Future Directions
Laura M. Spring et al.
CURRENT ONCOLOGY REPORTS (2019)
A Novel Autocrine CXCL14/ACKR2 Axis: The Achilles' Heel of Cancer Metastasis?
Qian Zhang et al.
CLINICAL CANCER RESEARCH (2019)
Intratumoral Activity of the CXCR3 Chemokine System Is Required for the Efficacy of Anti-PD-1 Therapy
Melvyn T. Chow et al.
IMMUNITY (2019)
SOX9 drives the epithelial-mesenchymal transition in non-small-cell lung cancer through the Wnt/-catenin pathway
Jing-Qiang Huang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
Combined quantitative measures of ER, PR, HER2, and KI67 provide more prognostic information than categorical combinations in luminal breast cancer
Mustapha Abubakar et al.
MODERN PATHOLOGY (2019)
CCL5 promotes breast cancer recurrence through macrophage recruitment in residual tumors
Andrea Walens et al.
ELIFE (2019)
NR2F1 contributes to cancer cell dormancy, invasion and metastasis of salivary adenoid cystic carcinoma by activating CXCL12/CXCR4 pathway
Xiao-lei Gao et al.
BMC CANCER (2019)
TSPAN8 promotes cancer cell stemness via activation of sonic Hedgehog signaling
Rongxuan Zhu et al.
NATURE COMMUNICATIONS (2019)
Immune checkpoint inhibitors of PD-L1 as cancer therapeutics
Akintunde Akinleye et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Cyclophosphamide Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression
Ali Roghanian et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Breast cancer
Nadia Harbeck et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
Phase I trial of HuMax-IL8 (BMS-986253), an anti-IL-8 monoclonal antibody, in patients with metastatic or unresectable solid tumors
Marijo Bilusic et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
When to Add Additional Anti-HER2 Therapy to Adjuvant Trastuzumab
Alexandra S. Zimmer et al.
CURRENT ONCOLOGY REPORTS (2019)
Microenvironmental IL1β promotes breast cancer metastatic colonisation in the bone via activation of Wnt signalling
Rachel Eyre et al.
NATURE COMMUNICATIONS (2019)
Endogenous Production of IL1B by Breast Cancer Cells Drives Metastasis and Colonization of the Bone Microenvironment
Claudia Tulotta et al.
CLINICAL CANCER RESEARCH (2019)
Targeting the perivascular niche sensitizes disseminated tumour cells to chemotherapy
Patrick Carlson et al.
NATURE CELL BIOLOGY (2019)
Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer
G. von Minckwitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
ERRα promotes breast cancer cell dissemination to bone by increasing RANK expression in primary breast tumors
G. Vargas et al.
ONCOGENE (2019)
Type I interferon/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancer
Qiang Lan et al.
ONCOGENE (2019)
Dual blockage of both PD-L1 and CD47 enhances immunotherapy against circulating tumor cells
Shu Lian et al.
SCIENTIFIC REPORTS (2019)
Th1 cytokines promotes E3 ubiquitin ligase CuIlin 5 expression via STAT1 signaling cascade and enhance cul5 mediated proteasomal degradation of HER2 in HER2+/ER- breast cancer
Yongsheng Jia et al.
CANCER RESEARCH (2019)
Combining RANK/RANKL and ERBB-2 targeting as a novel strategy in ERBB-2positive breast carcinomas
Ilianna Zoi et al.
BREAST CANCER RESEARCH (2019)
Neoadjuvant neratinib promotes ferroptosis and inhibits brain metastasis in a novel syngeneic model of spontaneous HER2(+ve) breast cancer metastasis
Aadya Nagpal et al.
BREAST CANCER RESEARCH (2019)
Tamoxifen enhances stemness and promotes metastasis of ERα36+ breast cancer by upregulating ALDH1A1 in cancer cells
Qiang Wang et al.
CELL RESEARCH (2018)
Expanded Genomic Profiling of Circulating Tumor Cells in Metastatic Breast Cancer Patients to Assess Biomarker Status and Biology Over Time (CALGB 40502 and CALGB 40503, Alliance)
Mark Jesus M. Magbanua et al.
CLINICAL CANCER RESEARCH (2018)
Time trends of overall survival among metastatic breast cancer patients in the real-life ESME cohort
Elisa Gobbini et al.
EUROPEAN JOURNAL OF CANCER (2018)
Chimeric Antigen Receptor T Cell Therapy: Challenges to Bench-to-Bedside Efficacy
Shivani Srivastava et al.
JOURNAL OF IMMUNOLOGY (2018)
IFN-γ orchestrates tumor elimination, tumor dormancy, tumor escape, and progression
Hussein F. Aqbi et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2018)
Enhanced preclinical antitumor activity of M7824, a bifunctional fusion protein simultaneously targeting PD-L1 and TGF-β
Yan Lan et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Extended release of perioperative immunotherapy prevents tumor recurrence and eliminates metastases
Chun Gwon Park et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Eradication of spontaneous malignancy by local immunotherapy
Idit Sagiv-Barfi et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations
Jun Gong et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
The Biology and Therapeutic Implications of Tumor Dormancy and Reactivation
Amit S. Yadav et al.
FRONTIERS IN ONCOLOGY (2018)
Disseminated tumour cells in bone marrow are the source of cancer relapse after therapy
Buqing Sai et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
Sanjeev Mariathasan et al.
NATURE (2018)
NK cells shape pancreatic and oral tumor microenvironments; role in inhibition of tumor growth and metastasis
Anahid Jewett et al.
SEMINARS IN CANCER BIOLOGY (2018)
High NRF2 level mediates cancer stem cell-like properties of aldehyde dehydrogenase (ALDH)-high ovarian cancer cells: inhibitory role of all-trans retinoic acid in ALDH/NRF2 signaling
Donghyeok Kim et al.
CELL DEATH & DISEASE (2018)
EMT and Stemness in Tumor Dormancy and Outgrowth: Are They Intertwined Processes?
Keren Weidenfeld et al.
FRONTIERS IN ONCOLOGY (2018)
Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancer
Davide Melisi et al.
BRITISH JOURNAL OF CANCER (2018)
Roles of the immune system in cancer: from tumor initiation to metastatic progression
Hugo Gonzalez et al.
GENES & DEVELOPMENT (2018)
Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1/VEGF signalling in MCF-7 breast cancer cells
Valerio Ciccone et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Dormant tumour cells, their niches and the influence of immunity
Erica T. Goddard et al.
NATURE CELL BIOLOGY (2018)
Implantable pre-metastatic niches for the study of the microenvironmental regulation of disseminated human tumour cells
Ryan A. Carpenter et al.
NATURE BIOMEDICAL ENGINEERING (2018)
Immune checkpoint inhibitors: recent progress and potential biomarkers
Pramod Darvin et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2018)
NR2F1 stratifies dormant disseminated tumor cells in breast cancer patients
Elin Borgen et al.
BREAST CANCER RESEARCH (2018)
Genomic and expression profiling reveal molecular heterogeneity of disseminated tumor cells in bone marrow of early breast cancer
Mark Jesus M. Magbanua et al.
NPJ BREAST CANCER (2018)
Usefulness of CTC and DTC-BM Detection for Adjuvant Therapy Effects and Prognosis Prediction in Early Breast Carcinoma: Results of 8-11 Years of Follow-up Evaluation
Hiroshi Takeyama et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
Circulating and disseminated tumour cells - mechanisms of immune surveillance and escape
Malte Mohme et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
CXCR4 inhibitors could benefit to HER2 but not to triple-negative breast cancer patients
S. Lefort et al.
ONCOGENE (2017)
Circulating and disseminated tumor cells: diagnostic tools and therapeutic targets in motion
Hongxia Wang et al.
ONCOTARGET (2017)
Novel TGF-β inhibitors ready for prime time in onco-immunology
Armand de Gramont et al.
ONCOIMMUNOLOGY (2017)
Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy
N. Masuda et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Combined immunotherapy with anti-PDL-1/PD-1 and anti-CD4 antibodies cures syngeneic disseminated neuroblastoma
Valentina Rigo et al.
SCIENTIFIC REPORTS (2017)
Phase I Study of a Poxviral TRICOM-Based Vaccine Directed Against the Transcription Factor Brachyury
Christopher R. Heery et al.
CLINICAL CANCER RESEARCH (2017)
Neutralization of IL-8 decreases tumor PMN-MDSCs and reduces mesenchymalization of claudin-low triple-negative breast cancer
Charli Dominguez et al.
JCI INSIGHT (2017)
Microenvironmental regulation of tumour angiogenesis
Michele de Palma et al.
NATURE REVIEWS CANCER (2017)
NR2F1 limits dissemination and stemness of early breast cancer cells
Maria Soledad Sosa
CANCER RESEARCH (2017)
Essential role of Notch4/STAT3 signaling in epithelial-mesenchymal transition of tamoxifen-resistant human breast cancer
Quyen Thu Bui et al.
CANCER LETTERS (2017)
Emerging Biological Principles of Metastasis
Arthur W. Lambert et al.
CELL (2017)
Genomic pathways modulated by Twist in breast cancer
Farhad Vesuna et al.
BMC CANCER (2017)
Design of Switchable Chimeric Antigen Receptor T Cells Targeting Breast Cancer
Yu Cao et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Metastatic Latency and Immune Evasion through Autocrine Inhibition of WNT
Srinivas Malladi et al.
CELL (2016)
Macrophage Metabolism Controls Tumor Blood Vessel Morphogenesis and Metastasis
Mathias Wenes et al.
CELL METABOLISM (2016)
10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study
Marissa C. van Maaren et al.
LANCET ONCOLOGY (2016)
Caveolin-1 in the regulation of cell metabolism: a cancer perspective
Zeribe Chike Nwosu et al.
MOLECULAR CANCER (2016)
METASTASIS Pathways of parallel progression
Cyrus M. Ghajar et al.
NATURE (2016)
Early dissemination seeds metastasis in breast cancer
Hedayatollah Hosseini et al.
NATURE (2016)
Mechanism of early dissemination and metastasis in Her2+ mammary cancer
Kathryn L. Harper et al.
NATURE (2016)
Induction of LIFR confers a dormancy phenotype in breast cancer cells disseminated to the, bone marrow
Rachelle W. Johnson et al.
NATURE CELL BIOLOGY (2016)
Dormant breast cancer micrometastases reside in specific bone marrow niches that regulate their transit to and from bone
Trevor T. Price et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
A hypoxic signature marks tumors formed by disseminated tumor cells in the BALB-neuT mammary cancer model
Aichi Msaki et al.
ONCOTARGET (2016)
Melanoma dormancy in a mouse model is linked to GILZ/FOXO3A-dependent quiescence of disseminated stem-like cells
Yasmine Touil et al.
SCIENTIFIC REPORTS (2016)
High Vimentin Expression Associated with Lymph Node Metastasis and Predicated a Poor Prognosis in Oral Squamous Cell Carcinoma
Shuli Liu et al.
SCIENTIFIC REPORTS (2016)
WNT4 mediates estrogen receptor signaling and endocrine resistance in invasive lobular carcinoma cell lines
Matthew J. Sikora et al.
BREAST CANCER RESEARCH (2016)
Disseminated tumor cells from the bone marrow of patients with nonmetastatic primary breast cancer are predictive of locoregional relapse
A. D. Hartkopf et al.
ANNALS OF ONCOLOGY (2015)
The Osteogenic Niche Promotes Early-Stage Bone Colonization of Disseminated Breast Cancer Cells
Hai Wang et al.
CANCER CELL (2015)
Dormant Cells: The Original Cause of Tumor Recurrence and Metastasis
Jie Li et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2015)
Stem cell biomarker ALDH1A1 in breast cancer shows an association with prognosis and clinicopathological variables that is highly cut-off dependent
Martin Sjostrom et al.
JOURNAL OF CLINICAL PATHOLOGY (2015)
Clinical and molecular complexity of breast cancer metastases
Siker Kimbung et al.
SEMINARS IN CANCER BIOLOGY (2015)
NR2F1 controls tumour cell dormancy via SOX9-and RAR beta-driven quiescence programmes
Maria Soledad Sosa et al.
NATURE COMMUNICATIONS (2015)
The generation and analyses of a novel combination of recombinant adenovirus vaccines targeting three tumor antigens as an immunotherapeutic
Elizabeth S. Gabitzsch et al.
ONCOTARGET (2015)
Caveolin-1 is Associated with Tumor Progression and Confers a Multi-Modality Resistance Phenotype in Pancreatic Cancer
Moumita Chatterjee et al.
SCIENTIFIC REPORTS (2015)
Phase I Trial of a Yeast-Based Therapeutic Cancer Vaccine (GI-6301) Targeting the Transcription Factor Brachyury
Christopher R. Heery et al.
CANCER IMMUNOLOGY RESEARCH (2015)
HER2-family signalling mechanisms, clinical implications and targeting in breast cancer
N. Elster et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Downregulation of CXCR4 in Metastasized Breast Cancer Cells and Implication in Their Dormancy
Kentaro Nobutani et al.
PLOS ONE (2015)
Metastasis prevention by targeting the dormant niche
Cyrus M. Ghajar
NATURE REVIEWS CANCER (2015)
Single cell mutational analysis of PIK3CA in circulating tumor cells and metastases in breast cancer reveals heterogeneity, discordance, and mutation persistence in cultured disseminated tumor cells from bone marrow
Glenn Deng et al.
BMC CANCER (2014)
The Inherent Premise of Immunotherapy for Cancer Dormancy
Masoud H. Manjili
CANCER RESEARCH (2014)
Molecular Mechanisms of Bone Metastasis and Associated Muscle Weakness
David L. Waning et al.
CLINICAL CANCER RESEARCH (2014)
The immune system and response to HER2-targeted treatment in breast cancer
Giampaolo Bianchini et al.
LANCET ONCOLOGY (2014)
PSMA-Specific CAR-Engineered T Cells Eradicate Disseminated Prostate Cancer in Preclinical Models
Gaia Zuccolotto et al.
PLOS ONE (2014)
Mechanisms of disseminated cancer cell dormancy: an awakening field
Maria Soledad Sosa et al.
NATURE REVIEWS CANCER (2014)
Pretreatment levels of circulating Th1 and Th2 cytokines, and their ratios, are associated with ER-negative and triple negative breast cancers
Chi-Chen Hong et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
TGF-β2 dictates disseminated tumour cell fate in target organs through TGF-β-RIII and p38α/β signalling
Paloma Bragado et al.
NATURE CELL BIOLOGY (2013)
Microenvironmental regulation of tumor progression and metastasis
Daniela F. Quail et al.
NATURE MEDICINE (2013)
Stem cell transcription factor NANOG controls cell migration and invasion via dysregulation of E-cadherin and FoxJ1 and contributes to adverse clinical outcome in ovarian cancers
M. K. Y. Siu et al.
ONCOGENE (2013)
Immunological targeting of tumor cells undergoing an epithelial-mesenchymal transition via a recombinant brachyury-yeast vaccine
Duane H. Hamilton et al.
ONCOTARGET (2013)
Regulatory networks defining EMT during cancer initiation and progression
Bram De Craene et al.
NATURE REVIEWS CANCER (2013)
Trastuzumab clears HER2/neu-positive isolated tumor cells from bone marrow in primary breast cancer patients
Brigitte Rack et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2012)
EMT and MET in Metastasis: Where Are the Cancer Stem Cells?
Thomas Brabletz
CANCER CELL (2012)
Expression of chemokine receptors on circulating tumor cells in patients with solid tumors
Alberto Fusi et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker
Dahu Chen et al.
NATURE MEDICINE (2012)
Dormancy Signatures and Metastasis in Estrogen Receptor Positive and Negative Breast Cancer
Ryung S. Kim et al.
PLOS ONE (2012)
ERK1/2 and p38α/β Signaling in Tumor Cell Quiescence: Opportunities to Control Dormant Residual Disease
Maria Soledad Sosa et al.
CLINICAL CANCER RESEARCH (2011)
Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone
Aya Kobayashi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma
Jo Eyles et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
CD4+ T Cells Regulate Pulmonary Metastasis of Mammary Carcinomas by Enhancing Protumor Properties of Macrophages
David G. DeNardo et al.
CANCER CELL (2009)
The RANKL signaling axis is sufficient to elicit ductal side-branching and alveologenesis in the mammary gland of the virgin mouse
Rodrigo Fernandez-Valdivia et al.
DEVELOPMENTAL BIOLOGY (2009)
Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients
Bahriye Aktas et al.
BREAST CANCER RESEARCH (2009)
Trastuzumab decreases the number of circulating and disseminated tumor cells despite trastuzumab resistance of the primary tumor
Mark Barok et al.
CANCER LETTERS (2008)
Vascular endothelial growth factor reduces tamoxifen efficacy and promotes metastatic colonization and desmoplasia in breast tumors
Zhican Qu et al.
CANCER RESEARCH (2008)
Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton
Dalit Barkan et al.
CANCER RESEARCH (2008)
Adaptive immunity maintains occult cancer in an equilibrium state
Catherine M. Koebel et al.
NATURE (2007)
Dormant cancer cells retrieved from metastasis-free organs regain tumorigenic and metastatic potency
Mika Suzuki et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
A pooled analysis of bone marrow micrometastasis in breast cancer
S Braun et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Genomic profiling of viable and proliferative micrometastatic cells from early-stage breast cancer patients
R Gangnus et al.
CLINICAL CANCER RESEARCH (2004)
分享论文
